Elli F. Kamper

951 total citations
26 papers, 767 citations indexed

About

Elli F. Kamper is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Elli F. Kamper has authored 26 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Hematology and 7 papers in Cancer Research. Recurrent topics in Elli F. Kamper's work include Protease and Inhibitor Mechanisms (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Elli F. Kamper is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Neuroscience and Neuropharmacology Research (3 papers). Elli F. Kamper collaborates with scholars based in Greece, United States and Germany. Elli F. Kamper's co-authors include Antonios Chatzigeorgiou, Konstantinos Kalafatakis, Antonios Halapas, Adrianos Nezos, John C. Stavridis, Vaggelis Harokopos, Vassilis Aidinis, Z. Papadopoulou‐Daifoti, Pothitos M. Pitychoutis and Apostolos Bossios and has published in prestigious journals such as Analytical Biochemistry, Frontiers in Immunology and Anesthesia & Analgesia.

In The Last Decade

Elli F. Kamper

26 papers receiving 739 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elli F. Kamper Greece 15 167 156 155 144 120 26 767
Murat Giriş Türkiye 18 190 1.1× 148 0.9× 169 1.1× 70 0.5× 123 1.0× 35 836
Shinobu Ikeda Japan 17 296 1.8× 181 1.2× 85 0.5× 109 0.8× 78 0.7× 41 920
Figen Gürdöl Türkiye 21 156 0.9× 102 0.7× 128 0.8× 93 0.6× 208 1.7× 61 966
Takafumi Taguchi Japan 17 203 1.2× 94 0.6× 215 1.4× 68 0.5× 148 1.2× 48 750
Éva Morschl Hungary 14 175 1.0× 165 1.1× 60 0.4× 161 1.1× 79 0.7× 26 828
David H. Jho United States 12 224 1.3× 212 1.4× 101 0.7× 96 0.7× 140 1.2× 23 929
M Dembiński Poland 18 148 0.9× 309 2.0× 95 0.6× 135 0.9× 109 0.9× 21 820
L. Daffonchio Italy 18 176 1.1× 143 0.9× 77 0.5× 152 1.1× 405 3.4× 65 932
I Simón Spain 18 240 1.4× 170 1.1× 156 1.0× 102 0.7× 233 1.9× 34 1.0k
László Bajnok Hungary 18 254 1.5× 278 1.8× 237 1.5× 75 0.5× 177 1.5× 42 989

Countries citing papers authored by Elli F. Kamper

Since Specialization
Citations

This map shows the geographic impact of Elli F. Kamper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elli F. Kamper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elli F. Kamper more than expected).

Fields of papers citing papers by Elli F. Kamper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elli F. Kamper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elli F. Kamper. The network helps show where Elli F. Kamper may publish in the future.

Co-authorship network of co-authors of Elli F. Kamper

This figure shows the co-authorship network connecting the top 25 collaborators of Elli F. Kamper. A scholar is included among the top collaborators of Elli F. Kamper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elli F. Kamper. Elli F. Kamper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mavragani, Clio P., Timothy B. Niewold, Antonios Chatzigeorgiou, et al.. (2013). Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations. Frontiers in Immunology. 4. 238–238. 18 indexed citations
2.
Chatzigeorgiou, Antonios, et al.. (2012). Extracellular matrix-associated (GAGs, CTGF), angiogenic (VEGF) and inflammatory factors (MCP-1, CD40, IFN-γ) in type 1 diabetes mellitus nephropathy. Clinical Chemistry and Laboratory Medicine (CCLM). 50(1). 167–74. 13 indexed citations
3.
Panagiotopoulos, Ιoannis, et al.. (2010). Alterations in biomarkers of endothelial function following on‐pump coronary artery revascularization. Journal of Clinical Laboratory Analysis. 24(6). 389–398. 16 indexed citations
4.
Chatzigeorgiou, Antonios, et al.. (2010). The antioxidant effect of angiotensin II receptor blocker, losartan, in streptozotocin-induced diabetic rats. Translational research. 156(1). 26–36. 39 indexed citations
5.
Chatzigeorgiou, Antonios, et al.. (2009). CD40/CD40L signaling and its implication in health and disease. BioFactors. 35(6). 474–483. 131 indexed citations
6.
7.
Kamper, Elli F., et al.. (2009). Sex differences in oxidant/antioxidant balance under a chronic mild stress regime. Physiology & Behavior. 98(1-2). 215–222. 70 indexed citations
8.
Gourgiotis, Dimitrios, et al.. (2006). Oxidative stress and adhesion molecules in children with type 1 diabetes mellitus: a possible link. Pediatric Diabetes. 7(1). 51–59. 39 indexed citations
9.
Arvanitis, Dimitrios, et al.. (2002). Tetranectin expression in gastric adenocarcinomas.. PubMed. 17(2). 471–5. 14 indexed citations
10.
Kamper, Elli F., et al.. (1999). Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clinical Biochemistry. 32(8). 639–645. 18 indexed citations
11.
Kamper, Elli F., et al.. (1999). Tetranectin, soluble P-selectin and VCAM-1 in the plasma of children with insulin-dependent diabetes mellitus. Fibrinolysis & proteolysis. 13(3). 148–153. 3 indexed citations
12.
Kamper, Elli F., et al.. (1998). Plasma tetranectin levels in patients with unstable and stable angina. Fibrinolysis & proteolysis. 12(6). 353–359. 4 indexed citations
13.
14.
Kamper, Elli F., et al.. (1998). Tetranectin Levels in Patients with Acute Myocardial Infarction and Their Alterations during Thrombolytic Treatment. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 35(3). 400–407. 21 indexed citations
15.
Kamper, Elli F., et al.. (1998). Modulation of rat brain synaptosomal plasma membrane achieved by atracurium and its metabolite laudanosine. Intensive Care Medicine. 24(5). 519–525. 4 indexed citations
16.
17.
Kamper, Elli F., et al.. (1997). Modulation of Synaptosomal Plasma Membrane-Bound Enzyme Activity Through the Perturbation of Plasma Membrane Lipid Structure by Bupivacaine. Anesthesia & Analgesia. 85(6). 1337–1343. 14 indexed citations
18.
19.
Kamper, Elli F., et al.. (1988). Activity of ribonuclease H in cells of chronic B‐lymphocytic leukaemia: correlation with clinical stage. British Journal of Haematology. 70(3). 301–306. 1 indexed citations
20.
Kamper, Elli F., et al.. (1987). Activity and Function of Hybrid Ribonuclease in Cells of Acute and Chronic Myelogenous Leukemia. Pathobiology. 55(3). 127–135. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Murat Giriş Breakdown of academic impact, for papers by Shinobu Ikeda Breakdown of academic impact, for papers by Figen Gürdöl Breakdown of academic impact, for papers by Takafumi Taguchi Breakdown of academic impact, for papers by Éva Morschl Breakdown of academic impact, for papers by David H. Jho Breakdown of academic impact, for papers by M Dembiński Breakdown of academic impact, for papers by L. Daffonchio Breakdown of academic impact, for papers by I Simón Breakdown of academic impact, for papers by László Bajnok
Rankless by CCL
2026